Clinical and cost-effectiveness of a home-based health promotion intervention for older people with mild frailty in England: a multicentre, parallel-group, randomised controlled trial
Authors
Claudia Cooper (ORCID: https://orcid.org/0000-0002-2777-7616)
Gillian Thornton
Andrew Paul Clegg (ORCID: https://orcid.org/0000-0001-5972-1097)
Jane Hopkins (ORCID: https://orcid.org/0000-0003-4042-9269)
Menzies Centre for Australian Studies, King's College London, University of London
Health Technology Assessment Programme
Leeds Biomedical Research Centre
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Clinical and cost-effectiveness of a home-based health promotion intervention for older people with mild frailty in England: a multicentre, parallel-group, randomised controlled trial
Claudia Cooper, Gillian Thornton, Andrew Paul Clegg, Jane Hopkins et al.
Citations
9 citations
Journal
The Lancet Healthy Longevity
Topics
Frailty in Older Adults
Field-Weighted Citation Impact (FWCI)
11.02
article
Clinical and cost-effectiveness of a home-based health promotion intervention for older people with mild frailty in England: a multicentre, parallel-group, randomised controlled trial
Claudia Cooper, Gillian Thornton, Andrew Paul Clegg, Jane Hopkins, Rachael Frost, Kate Walters, Kalpa Kharicha, Benjamin Gardner, Pip Logan, Vari Drennan, Rekha Elaswarapu, Rachael Hunter, Sarah Kalwarowsky, Christina Avgerinou, Louise Marston, Matthew Prescott, Rebecca L. Gould, Dawn A. Skelton, Claire Goodman, Shengning Pan, Farah Mahmood, C. Jowett
article en
9 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Healthy LongevityVol. 6(2)
Institutions
University of Leeds (GB), University of Bradford (GB), University of Nottingham (GB), Queen Mary University of London (GB), King's College London (GB), Glasgow Caledonian University (GB), Kingston University London (GB), Royal Institution of Chartered Surveyors (GB), University of Surrey (GB), Community Care (US), University College London (GB)
Funders
AstraZeneca, National Institute for Health and Care Excellence, UK Research and Innovation, National Institute for Health and Care Research, Department of Health and Social Care, British Geriatrics Society, Age UK, European Commission, University of Glasgow, Medical Research Council, Menzies Centre for Australian Studies, King's College London, University of London, Health Technology Assessment Programme, Leeds Biomedical Research Centre